WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Larissa Morgan
Associate
Regulatory
Seattle
lmorgan@wsgr.com

D206-883-2674

Download vCard
Open PDF

Larissa Morgan is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm's digital health industry group and healthcare practice. With a goal of simplifying the complex and layered world of health care regulation, Larissa counsels providers, payers, digital health companies, technology companies, and strategic investors on state and federal regulatory compliance matters, such as fraud and abuse laws, digital health, privacy, Medicare and Medicaid reimbursement, fee-splitting laws, corporate practice of medicine, and licensing standards. Larissa leverages her breadth of regulatory experience, along with her background in bioethics and health policy, to provide practical, comprehensive advice to her clients at every stage of their business, particularly in areas of emerging health innovation.

Larissa frequently serves as regulatory counsel on transactions and government investigations. She has assisted clients on complex, strategic transactions, joint ventures, and mergers and acquisitions, developing a regulatory plan and strategy, identifying and mitigating regulatory risks, ensuring compliance with state and federal requirements, and assessing the regulatory implications on a deal's life cycle. Larissa also supports clients undergoing government investigations and administrative proceedings for suspected non-compliance with state and federal health care laws, serving as a strategist between her clients and the government and helping her clients navigate intricate regulations.

Larissa was previously an associate in the health care group of Faegre Drinker in Philadelphia. During her time at Faegre, Larissa was also an adjunct professor at the University of Pennsylvania Carey Law School, where she co-instructed a regulatory law and policy seminar. Prior to attending law school, Larissa was a health insurance navigator at a public health organization in Philadelphia, where she specialized in health enrollment policy and services related to Medicaid and health insurance marketplace products.

Larissa is an avid writer and speaker on health care regulatory matters, and her work has previously been cited by the Centers for Disease Control and Prevention.

Experience

Larissa Morgan is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm's digital health industry group and healthcare practice. With a goal of simplifying the complex and layered world of health care regulation, Larissa counsels providers, payers, digital health companies, technology companies, and strategic investors on state and federal regulatory compliance matters, such as fraud and abuse laws, digital health, privacy, Medicare and Medicaid reimbursement, fee-splitting laws, corporate practice of medicine, and licensing standards. Larissa leverages her breadth of regulatory experience, along with her background in bioethics and health policy, to provide practical, comprehensive advice to her clients at every stage of their business, particularly in areas of emerging health innovation.

Larissa frequently serves as regulatory counsel on transactions and government investigations. She has assisted clients on complex, strategic transactions, joint ventures, and mergers and acquisitions, developing a regulatory plan and strategy, identifying and mitigating regulatory risks, ensuring compliance with state and federal requirements, and assessing the regulatory implications on a deal's life cycle. Larissa also supports clients undergoing government investigations and administrative proceedings for suspected non-compliance with state and federal health care laws, serving as a strategist between her clients and the government and helping her clients navigate intricate regulations.

Larissa was previously an associate in the health care group of Faegre Drinker in Philadelphia. During her time at Faegre, Larissa was also an adjunct professor at the University of Pennsylvania Carey Law School, where she co-instructed a regulatory law and policy seminar. Prior to attending law school, Larissa was a health insurance navigator at a public health organization in Philadelphia, where she specialized in health enrollment policy and services related to Medicaid and health insurance marketplace products.

Larissa is an avid writer and speaker on health care regulatory matters, and her work has previously been cited by the Centers for Disease Control and Prevention.

Education
  • J.D., University of Pennsylvania Carey Law School, 2021
  • Master of Bioethics, University of Pennsylvania, 2021
  • B.A., Psychology, Villanova University, 2017
  • B.A., Political Science, Villanova University, 2017Minor in Writing and Rhetoric
Associations and Memberships
  • Member, American Health Law Association
  • Editorial Board Member, American Health Law Association, Journal of Health and Life Sciences Law
Honors
  • Recipient, City of Philadelphia Distinguished National Service Alumni Award, 2020
Admissions
  • State Bar of Washington
  • State Bar of Pennsylvania
Credentials
Education
  • J.D., University of Pennsylvania Carey Law School, 2021
  • Master of Bioethics, University of Pennsylvania, 2021
  • B.A., Psychology, Villanova University, 2017
  • B.A., Political Science, Villanova University, 2017Minor in Writing and Rhetoric
Associations and Memberships
  • Member, American Health Law Association
  • Editorial Board Member, American Health Law Association, Journal of Health and Life Sciences Law
Honors
  • Recipient, City of Philadelphia Distinguished National Service Alumni Award, 2020
Admissions
  • State Bar of Washington
  • State Bar of Pennsylvania

Select Publications

  • Co-author, The Complete Health Lawyer, Minnesota Continuing Legal Education, April 1, 2026
  • Co-author, Healthcare Employment Practice: Policy, Law, and Procedure, Practising Law Institute, October 2025, Updated September 2026
  • Co-author, “The Booming Business of Botox - Legal Considerations for Medical Spas,” American Health Law Association, May 16, 2025
  • Co-author, “As Pharmacists' Expanded Scope of Practice Winds Down Post-PHE, What Stays and What Goes?,” National Association of Boards of Pharmacy, May 2023
  • Co-author, “Health Care Compliance in a Post-Pandemic World,” Compliance Today Magazine, May 2023
  • Co-author, “DEA's Proposed Rules on Controlled Substances Prescribing via Telemedicine and Their Uncertain Impact on the Pharmacy Community,” Pharmacy Times, April 28, 2023
  • Author, “Operating Under the Radar: IV Hydration Therapy and Risks to Patient Health,” National Association of Boards of Pharmacy, November 2022
  • Co-author, “DEA Seeks Public Input as it Explores Regulating Telepharmacy,” National Association of Boards of Pharmacy, February 18, 2022
  • Corresponding Author, “COVID-19 Vaccination of Minors Without Parental Consent,” JAMA Pediatrics, July 12, 2021

Select Speaking Engagements

  • Presenter, Anti-kickback Statute and False Claims Act, Minnesota Continuing Legal Education, April 1, 2026
  • Presenter, Health Care Compliance in a Post-Pandemic World, Health Care Compliance Association Annual Webinar, July 20, 2023
Insights

Select Publications

  • Co-author, The Complete Health Lawyer, Minnesota Continuing Legal Education, April 1, 2026
  • Co-author, Healthcare Employment Practice: Policy, Law, and Procedure, Practising Law Institute, October 2025, Updated September 2026
  • Co-author, “The Booming Business of Botox - Legal Considerations for Medical Spas,” American Health Law Association, May 16, 2025
  • Co-author, “As Pharmacists' Expanded Scope of Practice Winds Down Post-PHE, What Stays and What Goes?,” National Association of Boards of Pharmacy, May 2023
  • Co-author, “Health Care Compliance in a Post-Pandemic World,” Compliance Today Magazine, May 2023
  • Co-author, “DEA's Proposed Rules on Controlled Substances Prescribing via Telemedicine and Their Uncertain Impact on the Pharmacy Community,” Pharmacy Times, April 28, 2023
  • Author, “Operating Under the Radar: IV Hydration Therapy and Risks to Patient Health,” National Association of Boards of Pharmacy, November 2022
  • Co-author, “DEA Seeks Public Input as it Explores Regulating Telepharmacy,” National Association of Boards of Pharmacy, February 18, 2022
  • Corresponding Author, “COVID-19 Vaccination of Minors Without Parental Consent,” JAMA Pediatrics, July 12, 2021

Select Speaking Engagements

  • Presenter, Anti-kickback Statute and False Claims Act, Minnesota Continuing Legal Education, April 1, 2026
  • Presenter, Health Care Compliance in a Post-Pandemic World, Health Care Compliance Association Annual Webinar, July 20, 2023
Focus Areas
  • AI in Healthcare
  • Corporate
  • Digital Health
  • Healthcare and FDA Regulatory
  • Life Sciences
  • Mergers & Acquisitions
  • Regulatory
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Cookie Settings
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.